Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
MeiraGTx Holdings is a US-based biopharmaceutical company focused on the research and development of innovative gene therapies. The company drives the clinical development of novel therapeutics to treat severe diseases and address unmet medical needs.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
MeiraGTx Holdings is scheduled to report its next quarterly earnings on 11/18/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
MeiraGTx Holdings last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 1.71 USD.
Across its last 3 earnings reports, MeiraGTx Holdings stock moved by ±1.1% on average the following day. The largest reaction was -2% on 11/06/2025; 0 of 3 reactions were positive.
MeiraGTx Holdings has beaten analyst EPS estimates in 4 of its last 6 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.